Category Specific RSS

liz dallimore

Argenica completes production of brain stroke drug, prepares for Phase 2 trial

Biotech company Argenica Therapeutics Limited (ASX: AGN), which is developing novel therapeutics to reduce brain tissue death after stroke, has…

2 years ago

Argenica begins clinical trials of drug that could protect your brain during a stroke

Every 19 minutes, an Australian suffers a stroke, and every hour that the treatment is delayed, the brain ages up…

3 years ago